About

Subscribe

Contact

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is gaining momentum in clinical settings, with compounds like psilocybin, MDMA, and DMT being studied for their potential to treat PTSD, anxiety, depression, and addiction. This section explores trial data, therapeutic frameworks, FDA designations, and the evolving ethics around integration into psychiatric practice.

psilocybin depression treatment effectiveness

Psilocybin vs Antidepressants: Which Is Better?

March 31, 2026

psilocybin brain wave changes

Brain Waves May Predict Psilocybin Response

March 30, 2026

Psilocybin Neuroplasticity Mechanism

New Evidence Explains How Psilocybin Works

March 29, 2026

DMT Depression Treatment

Can a Single DMT Dose Reverse Depression?

March 21, 2026

Psilocybin Smoking Cessation Therapy

From Cigarettes to Psilocybin? A New Approach to Quitting

March 20, 2026

Psychedelic Therapy Commercialization

The Hidden Risk In Psychedelic Therapy Commercialization

March 14, 2026

Psilocybin Dose Dependent Effects

Why Psilocybin Dose May Matter More Than We Thought

March 11, 2026

Seizures

LSD and Seizures: A Research Signal Worth Watching

March 3, 2026

Ayahuasca and Fear

Ayahuasca and Fear: The Part No One Explains

February 21, 2026

Metabolic Effects

Metabolic Effects Without the Trip? What We Know

February 20, 2026

Back Next

Categories

Latest Articles

Join Our Email List

Sign up to receive the latest articles right in your inbox.